Is there any point to vasovagal syncope?

被引:38
|
作者
van Dijk, J. Gert [1 ]
Sheldon, Robert [2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Neurol & Clin Neurophysiol, NL-2300 RC Leiden, Netherlands
[2] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada
关键词
D O I
10.1007/s10286-008-0484-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The above considerations do not provide a definite answer regarding the putative meaning of VVS. We add to the confusion by suggesting two new hypotheses (the last two), even if there are perhaps already too many theories for the number of facts. The animal reflexes provide only fragmentary bases for the human reflex, and explain almost none of its clinical richness. The critical link between the animal precursor and human syncope is unknown. We do feel that VVS in its current form cannot be considered beneficial. Even if it is based on a beneficial principle, its expression suggests a response that has gone out of control. Are there ways to prove or disprove any of these hypotheses? Perhaps there are; at present we know the pathway of the reflex from the brainstem nuclei to the effector mechanisms. Hardly anything is known about the afferent pathway, however. It seems unlikely that standing and fear have completely identical afferent pathways. The organ giving off signals that set the reflex in motion needs to be identified. If central hypovolemia is involved in VVS evoked by standing, it may be possible to find out whether receptors in, for instance, abdominal underfilled veins or arteries are involved. If this succeeds, people with clear fear-induced VVS can be investigated to see if this mechanism operates in them as well. Once these paths are better known, perhaps we can identify the origin or origins of this oddest of reflexes.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [41] Brugada syndrome and vasovagal syncope
    Patruno, N
    Pontillo, D
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (02): : 215 - 215
  • [42] Drug treatment of vasovagal syncope
    Raviele, A
    Themistoclakis, S
    Gasparini, G
    NEURALLY MEDIATED SYNCOPE: PATHOPHYSIOLOGY, INVESTIGATIONS, AND TREATMENT, 1996, 10 : 113 - 117
  • [43] Autonomic nervous system changes in vasovagal syncope: is there any difference between young and elderly patients?
    Kochiadakis, GE
    Igoumenidis, NE
    Marketou, ME
    Kanoupakis, EM
    Simantirakis, EN
    Vardas, PE
    EUROPEAN HEART JOURNAL, 2000, 21 : 8 - 8
  • [44] Malignant vasovagal syncope in children
    Wen-Rui Xu
    Hong-Fang Jin
    Jun-Bao Du
    Ying Liao
    World Journal of Pediatrics, 2025, 21 (1) : 41 - 47
  • [45] ON THE TRIGGERING MECHANISM OF VASOVAGAL SYNCOPE
    HENRY, JP
    PSYCHOSOMATIC MEDICINE, 1984, 46 (02): : 91 - 93
  • [46] Vasovagal syncope: state or trait?
    Bizios, Anna Serletis
    Sheldon, Robert S.
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (01) : 68 - 73
  • [47] Prevalence of Fibromyalgia in Vasovagal Syncope
    Vallejo, Maite
    Martinez-Martinez, Laura-Aline
    Grijalva-Quijada, Saulo
    Olguin-Ruvalcaba, Hector-Manuel
    Salas, Elizabeth
    Hermosillo, Antonio G.
    Cardenas, Manuel
    Martinez-Lavin, Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (03) : 111 - 114
  • [48] Malignant convulsive vasovagal syncope
    Amasyali, B.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (04) : 212 - 212
  • [49] Cardiorespiratory interaction in vasovagal syncope
    Baruah, Resham
    Francis, Darrel P.
    Sutton, Richard
    HEART, 2008, 94 (11) : 1372 - 1373
  • [50] Circadian variation of vasovagal syncope
    Mineda, Y
    Sumiyoshi, M
    Tokano, T
    Yasuda, M
    Nakazato, K
    Nakazato, Y
    Nakata, Y
    Yamaguchi, H
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (10) : 1078 - 1080